First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness

New AHRQ Monograph Addresses Mental Health: First- Versus Second-Generation Antipsychotics

A continuing-education monograph from AHRQ is now available that compares individual first- and second-generation antipsychotic medications in adults with schizophrenia, schizophrenia-related psychoses or bipolar disorder. The monograph, based on a comparative effectiveness review from AHRQ’s Effective Health Care Program, reviews evidence comparing the effectiveness and side effects of individual drugs and lists questions for patients and health care providers to consider before choosing a treatment.

In addition to this new resource, previous materials related to this subject include the following:

• A consumer summary of antipsychotic medications for adults
• A clinician research summary that outlines the clinical bottom line of this comparative effectiveness review
• An educational slide set for clinicians to share the evidence with colleagues and students

The full research review.